newsfilter
← Latest News
CNBC·

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of AbbVie's buyout of ImmunoGen.